AFJOG

S0 ® Contains the smallest endosomal iron particles with 99 % relative bioavailability & no expected digestive system side effects or cellular toxicity 1,4-6 FROM THE EXPERTS IN IRON TECHNOLOGY 1-4 FERROUS FORTE® SOMAL - IT’S WHAT’S ON THE INSIDE THAT MATTERS References: 1. Ferrous Forte® Somal professional information, August 2022. 2. Ferrous Forte® Tablets professional information, September 2021. 3. Kim HJ, Bae SH, Kim HJ, et al . Cytotoxicity, Intestinal Transport, and Bioavailability ofDispersible IronandZincSupplements. FrontMicrobiol .2017;8:749.doi:10.3389/fmicb.2017.00749. 4. Dataonfile, iNovaPharmaceuticals.2022. 5. Sucrosomial ironpatentdocument. 6. Dataonfile, iNovaPharmaceuticals2024. Schedulingstatus: S0 Proprietaryname(anddosageform): FerrousForte®Somal. Composition: Eachcapsulecontains:24mgelemental iron(fromSunActive™ ferricpyrophosphate.SunActive™ isaregisteredtrademark of Taiyo Kagaku Co., Ltd), 350 mcg folic acid (from Magnafolate™ C, a registered trademark of Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd), 15 mcg vitamin B12, 60 mg vitamin C. Complementary Medicines: Health Supplement.D34.12Multiplesubstance formulation.Thisunregisteredmedicinehasnotbeenevaluatedby theSAHPRA for itsquality,safetyor intendeduse.For fullprescribing information, refer to theprofessional information availableatwww.inovapharma.co.za.Further information isavailableon request from iNovaPharmaceuticals. Nameandbusinessaddressofapplicant: iNovaPharmaceuticals (Pty)Ltd Co.Reg.No. 1952/001640/07,15E RileyRoad,Bedfordview. Tel.No .0110870000.25469L. IN2499/25. WHO:WorldHealthOrganisation AWARD WINNING TECHNOLOGY ENDORSED BY THE WHO 4 PHARMACY MAGAZINE AD